URI Z GOLDBERG

Allopathic & Osteopathic Physicians|Family Medicine TOLEDO, OR NPI 1902809502

General Payments — all program years on this page

$697.33

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 32
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $423.72 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $423.7219

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $24.701
2019 $90.216
2020 $35.912
2023 $122.794
2024 $423.7219

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096628077 Novo Nordisk Inc $14.91 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096974324 Novo Nordisk Inc $17.65 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097036619 Novo Nordisk Inc $18.08 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097615240 Novo Nordisk Inc $20.82 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104237979 AstraZeneca Pharmaceuticals LP $59.99 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104660587 AstraZeneca Pharmaceuticals LP $14.07 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105209318 AstraZeneca Pharmaceuticals LP $15.82 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105232437 AstraZeneca Pharmaceuticals LP $19.65 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105385210 AstraZeneca Pharmaceuticals LP $14.58 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105542221 AstraZeneca Pharmaceuticals LP $16.24 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114677126 Exact Sciences Corporation $20.59 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114677131 Exact Sciences Corporation $24.35 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118228655 Boehringer Ingelheim Pharmaceuticals, Inc. $24.00 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118228657 Boehringer Ingelheim Pharmaceuticals, Inc. $25.00 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135439734 Lilly USA, LLC $28.61 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135462765 Lilly USA, LLC $16.64 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135487368 Lilly USA, LLC $13.22 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135504302 Lilly USA, LLC $31.68 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139369599 Astellas Pharma US Inc $27.82 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.